Skip to main content
Log in

"Essential" hep C drugs: cost effective but unaffordable?

  • Comment
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Urrutia J, et al. What does it mean to put new hepatitis C drugs on a list of essential medicines? BMJ : 22 Apr 2016. Available from: URL: http://dx.doi.org/10.1136/bmj.i2035

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

"Essential" hep C drugs: cost effective but unaffordable?. PharmacoEcon Outcomes News 752, 1 (2016). https://doi.org/10.1007/s40274-016-2995-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-016-2995-3

Navigation